YpsoDose – The worry-free and intuitive large-volume patch injector

YpsoDose is the pre-filled, ready-to-use patch injector designed for subcutaneous delivery of volumes up to 10 mL. With a powerful drive system capable of delivering 10 mL of 50 cp in 10 minutes, and an optimized fluid path that ensures minimal residual volume, YpsoDose supports a broad range of formulation and injection requirements. Its intuitive design ensures reliable, comfortable injections across conditions and environments. 

It is more than a device – it is a reliable partner for patients, caregivers, and healthcare providers. 

YpsoDose wearable injector for high-volume biologics; injector shows fill level and status light.

Fully industrialized and qualified manufacturing

YpsoDose Imagemovie
YpsoDose - Side view
YpsoDose - Side view

A unique set of advanced features Designed for safety and efficiency

  • Pre-filled, ready-to-use: Reduces device handling complexity, prevents patient interference with sterile components and mitigates user errors.
  • Minimal residual volume (cartridge & fluid path): A key advantage of YpsoDose that helps reduce drug waste and preserve high-value biologics, addressing a critical need for pharmaceutical manufacturers.
  • Powerful drive unit (e.g. 10 mL / 50 cp injected in 10 min): Enables reliable subcutaneous delivery of high-viscosity, complex biologics — supporting a broader range of formulation properties.

Excellence in patient centricity Patch and inject

  • Minimum and most simple use steps: No cartridge or drug handling required — with just a push of a button, YpsoDose enables a seamless and hassle-free injection experience, empowering patients to take control of their treatment with confidence.
  • Skin contact detection with electronic sensors: Ensures correct application and safety before, during and after injection.
  • Reliable injection under variable conditions: Enables reliable subcutaneous delivery across varying temperatures, orientations, and injection sites.
  • Ensures clear communication via audio and visual signals before, during, and after injection: Provides real-time feedback to patients and caregivers, increasing confidence and reducing uncertainty during administration.
Man injecting medication into his abdomen using YpsoDose autoinjector. Ease of use offers patients control of their treatment.
YpsoDose self-injection device open, showing internal mechanisms and needle safety features.

State-of-the-art technology For reliable and precise delivery

  • Built-in sterilityTM: Allows final assembly outside a cleanroom, making self-care safer, simpler, and easier.
  • Precise dose delivery (push-on-plunger drive): Smart drive system ensures consistent and complete injections — supporting dosing accuracy across varying conditions.
  • Injection speed up to 3.0 mL/min: Enables optimization of injection time for specific formulations and therapy needs.

Integrated collaboration support by Ypsomed

Ypsomed ensures a streamlined supply chain from primary packaging to fill & finish and final assembly, facilitating rapid clinical and commercial deployment.

SCHOTT Pharma: Leading glass cartridge partner

Ypsomed partners with SCHOTT Pharma, a leader in drug containment solutions, to ensure optimal drug stability with SCHOTT Pharma's cartriQ® technology.

  • Improved Type I FIOLAX® borosilicate glass for high chemical resistance 
  • 20% lower hydrolytic resistance limit (ISO 4802-2) to support long-term stability 
  • State-of-the-art siliconization process ensures low free silicone, minimizing particle load   
  • Prequalified elastomers tailored for biologics compatibility 
  • Tight geometrical dimensions enhance dosing accuracy and performance
  • Available in a ready-to-use (RTU) nest and tub configuration, reducing process steps in fill-and-finish operations and providing unparalleled flexibility

ten23 health: A tailored option for accelerated clinical and market entry

YpsoDose and ten23 health offer an integrated solution for subcutaneous self-administration of large-volume injectables, significantly accelerating time to clinic and market with ten23’s filling and final assembly options. This partnership provides pharmaceutical customers with a rigorously tested, validated platform, enabling them to focus on their core initiatives while expediting the path from clinic to market.

Dimensions and specifications Facts and figures

YpsoDose device dimensions: top view and side view are shown, with measurements indicated.
Device specifications
  • Primary container10 mL cartriQ®
  • Fill volume2.0 – 10.0 mL
  • Injection flow rate0.3 - 3.0 mL/min
  • DosingFixed dose for each device version
  • ViscosityMotor-driven allows broad range (e.g., 10 mL, 50 cp solution in 10 mins)
  • Fluid path/needle25 - 29G
  • Injection timeProgrammable for each customer version
  • Needle systemAutomated insertion and retraction
  • Needle insertion depth5 – 10 mm
  • Injection feedbackVisual and audible feedback before, during and after injection

Do you have a question about this product?

If you’d like more information or have a specific request, simply fill out the form below and our team will get back to you as soon as possible.

Contact us
Your details

Note:

We only use the data you provide us with on this form for the above-mentioned purpose. We do not save the data on this web server. For more information on the collection and processing of your data, please refer to our Privacy Policy.

Please calculate 3 plus 1.

* Mandatory fields

Resources & expert insights on YpsoDose

YpsoDose product brochure

Related blog posts